Page last updated: 2024-11-02

oxymetazoline and Blepharospasm

oxymetazoline has been researched along with Blepharospasm in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Blepharospasm: Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.

Research Excerpts

ExcerptRelevanceReference
"Administering botulinum toxin for the treatment of blepharospasm in patients A and B yielded the expected results; adding oxymetazoline hydrochloride ophthalmic solution (0."8.12Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series. ( Song, A; Song, J; Song, M; Sung, J, 2022)
"Administering botulinum toxin for the treatment of blepharospasm in patients A and B yielded the expected results; adding oxymetazoline hydrochloride ophthalmic solution (0."4.12Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series. ( Song, A; Song, J; Song, M; Sung, J, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sung, J1
Song, A1
Song, M1
Song, J1

Other Studies

1 other study available for oxymetazoline and Blepharospasm

ArticleYear
Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series.
    Journal of medical case reports, 2022, Aug-05, Volume: 16, Issue:1

    Topics: Blepharoptosis; Blepharospasm; Botulinum Toxins; Botulinum Toxins, Type A; Female; Humans; Middle Ag

2022